{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:45:32Z","timestamp":1792615532299,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10812-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:11:10Z","timestamp":1752577870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Methylation status of GSTP1 and APC promoter genes as potential biomarkers for early detection and tumor aggressiveness in prostate cancer: insights from a Moroccan cohort"],"prefix":"10.1007","volume":"52","author":[{"given":"Imane","family":"Mharrach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouna","family":"Aqerrout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoutar Anouar","family":"Tadlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelilah","family":"Laraqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouar El","family":"Ghazzaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moulay Mustapha","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"10812_CR1","first-page":"229","volume":"743","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 743:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"10812_CR2","doi-asserted-by":"crossref","unstructured":"Bizuayehu HM et al (2024) Global Disparities of Cancer and Its Projected Burden in 2050. JAMA network open 7(11):e2443198.","DOI":"10.1001\/jamanetworkopen.2024.43198"},{"key":"10812_CR3","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1016\/j.respe.2018.03.103","volume":"66","author":"F Salmi","year":"2018","unstructured":"Salmi F, Jouhadi H (2018) \u00c9tude du profil \u00e9pid\u00e9miologique du cancer de La prostate Dans Une population Marocaine. Rev Epidemiol Sante Publique 66:S157","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"1","key":"10812_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3892\/mmr.2015.3402","volume":"12","author":"W Zhang","year":"2015","unstructured":"Zhang W et al (2015) Correlation between the expression of DNMT1, and GSTP1 and APC, and the methylation status of GSTP1 and APC in association with their clinical significance in prostate cancer. Mol Med Rep 12(1):141\u2013146","journal-title":"Mol Med Rep Vol"},{"key":"10812_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CLEP.S16747","volume":"4","author":"MF Leitzmann","year":"2012","unstructured":"Leitzmann MF, Rohrmann S (2012) Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates. Clin Epidemiol 4:1\u201311","journal-title":"Clin Epidemiol"},{"issue":"2","key":"10812_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrg2507","volume":"10","author":"JS Witte","year":"2009","unstructured":"Witte JS (2009) Prostate cancer genomics: towards a new Understanding. Nat Reviews Genet 10(2):77\u201382","journal-title":"Nat Reviews Genet Vol"},{"issue":"2","key":"10812_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.canlet.2011.12.026","volume":"342","author":"C Jer\u00f3nimo","year":"2014","unstructured":"Jer\u00f3nimo C, Henrique R (2014) Epigenetic biomarkers in urological tumors: A systematic review. Cancer Lett 342(2):264\u2013274","journal-title":"Cancer Lett"},{"issue":"3","key":"10812_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/jnci\/djy141","volume":"111","author":"SG Zhao","year":"2019","unstructured":"Zhao SG, Lehrer J, Chang SL et al (2019) The immune landscape of prostate Cancer and nomination of PD-L2 as a potential therapeutic target. J Natl Cancer Inst 111(3):301\u2013310","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10812_CR9","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1158\/1078-0432.CCR-08-2784","volume":"15","author":"MT McCabe","year":"2009","unstructured":"McCabe MT, Brandes JC, Vertino PM (2009) Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res 15(12):3927\u20133937","journal-title":"Clin Cancer Res"},{"key":"10812_CR10","doi-asserted-by":"crossref","unstructured":"Pidsley R et al Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer. BJUI Compass 5(12):1299\u20131306.","DOI":"10.1002\/bco2.445"},{"issue":"10","key":"10812_CR11","first-page":"e72055","volume":"16","author":"M Aqerrout","year":"2024","unstructured":"Aqerrout M, Mharrach I, Anouar Tadlaoui K et al (2024) Adenomatous polyposis coli (APC) promoter gene methylation in Urine-Derived DNA: A Non-invasive biomarker for early bladder Cancer detection and tumor aggressiveness. Cureus 16(10):e72055","journal-title":"Cureus"},{"key":"10812_CR12","doi-asserted-by":"crossref","unstructured":"Malempati S, Agrawal N, Ravisankar D, Kothapalli VSRT, Cheemanapalli S, Tamanam RR et al (2024) Role of GSTP1 functional polymorphisms in molecular pathogenesis of colorectal cancer. Hum Gene.","DOI":"10.1016\/j.humgen.2024.201335"},{"key":"10812_CR13","doi-asserted-by":"crossref","unstructured":"Martignano F et al (2016) GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications. Disease markers (2016)","DOI":"10.1155\/2016\/4358292"},{"issue":"3","key":"10812_CR14","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4111\/kju.2012.53.3.200","volume":"53","author":"H-Y Yoon","year":"2012","unstructured":"Yoon H-Y et al (2012) DNA methylation of GSTP1 in human prostate tissues: pyrosequencing analysis. Korean J Urol 53(3):200\u2013205","journal-title":"Korean J Urol Vol"},{"issue":"7","key":"10812_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/1087057112444445","volume":"17","author":"HY Yoon","year":"2012","unstructured":"Yoon HY, Kim SK, Kim YW et al (2012) Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis. J Biomol Screen 17(7):987\u2013992","journal-title":"J Biomol Screen"},{"issue":"10","key":"10812_CR16","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1111\/j.1464-410X.2009.09167.x","volume":"105","author":"V Ph\u00e9","year":"2010","unstructured":"Ph\u00e9 V, Cussenot O, Roupr\u00eat M (2010) Methylated genes as potential biomarkers in prostate cancer. BJU Int 105(10):1364\u20131370","journal-title":"BJU Int"},{"key":"10812_CR17","first-page":"8","volume":"109","author":"Zhang","year":"2017","unstructured":"Zhang, Lu, Jerry W, Shay (2017) Multiple roles of APC and its therapeutic implications in colorectal Cancer. J Natl Cancer Inst 109:8","journal-title":"J Natl Cancer Inst Vol"},{"key":"10812_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4111\/kju.2013.54.3.194","volume":"543","author":"HY Yoon","year":"2013","unstructured":"Yoon HY, Kim YW, Kang HW, Kim WT, Yun SJ, Lee SC et al (2013) Pyrosequencing analysis of APC methylation level in human prostate tissues: A molecular marker for prostate cancer. Korean J Urol 543:194\u2013198","journal-title":"Korean J Urol"},{"key":"10812_CR19","doi-asserted-by":"publisher","first-page":"1182727","DOI":"10.3389\/fonc.2023.1182727","volume":"13","author":"HJ Shin","year":"2023","unstructured":"Shin HJ, Hua JT, Li H (2023) Recent advances in Understanding DNA methylation of prostate cancer. Front Oncol 13:1182727","journal-title":"Front Oncol"},{"key":"10812_CR20","doi-asserted-by":"crossref","unstructured":"Moreira-Barbosa C et al (2018) Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients. Clin Epigenetics 10(1):132.","DOI":"10.1186\/s13148-018-0564-2"},{"key":"10812_CR21","unstructured":"Esteller M, Sparks A, Toyota M, Sanchez C\u00e9spedes M, Capell\u00e1 G, Peinado M et al (2000) Analysis of adenomatous polyposis coli promoter hypermethylation in human Cancer1. Cancer Res. 60"},{"issue":"18","key":"10812_CR22","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, My\u00f6h\u00e4nen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG Islands. Proc Natl Acad Sci U S A 93(18):9821\u20139826","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10812_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0002-9440(10)63511-0","volume":"163","author":"GH Kang","year":"2003","unstructured":"Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS (2003) Aberrant CpG Island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163(4):1551\u20131556","journal-title":"Am J Pathol"},{"issue":"10","key":"10812_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.4161\/cbt.3.10.1113","volume":"3","author":"CN Arnold","year":"2004","unstructured":"Arnold CN, Goel A, Niedzwiecki D, Dowell JM, Wasserman L, Compton C et al (2004) APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q. Cancer Biol Ther 3(10):960\u2013964","journal-title":"Cancer Biol Ther"},{"key":"10812_CR25","doi-asserted-by":"crossref","unstructured":"Lavoro A et al (2025) Recent advances on gene-related DNA methylation in cancer diagnosis, prognosis, and treatment: a clinical perspective. Clinical epigenetics 17(1):76.","DOI":"10.1186\/s13148-025-01884-2"},{"key":"10812_CR26","doi-asserted-by":"crossref","unstructured":"Saleem MA, Mustafa S, Mustafa (2024) Promoter hypermethylation of the BRCA1 gene as a novel biomarker for prostate cancer. Cureus. 16(8):e66467.","DOI":"10.7759\/cureus.66467"},{"key":"10812_CR27","doi-asserted-by":"publisher","first-page":"1191311","DOI":"10.3389\/fendo.2023.1191311","volume":"14","author":"J Imamura","year":"2023","unstructured":"Imamura J, Ganguly S, Muskara A, Liao RS, Nguyen JK, Weight C et al (2023) Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution. Front Endocrinol (Lausanne) 14:1191311","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10812_CR28","doi-asserted-by":"crossref","unstructured":"Logotheti S et al (2023) Sep. Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated Omics Approaches to Explore Measurable Metrics. Cancers 15(17):4357.","DOI":"10.3390\/cancers15174357"},{"issue":"19","key":"10812_CR29","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1200\/JCO.2008.18.2485","volume":"27","author":"L Richiardi","year":"2009","unstructured":"Richiardi L, Fiano V, Vizzini L et al (2009) Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J Clin Oncol 27(19):3161\u20133168","journal-title":"J Clin Oncol"},{"issue":"5","key":"10812_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000318017","volume":"77","author":"I Steiner","year":"2010","unstructured":"Steiner I et al (2010) Gene promoter methylation and its potential relevance in early prostate cancer diagnosis. Pathobiology: J Immunopathol Mol Cell Biology 77(5):260\u2013266","journal-title":"Pathobiology: J Immunopathol Mol Cell Biology Vol"},{"key":"10812_CR31","doi-asserted-by":"crossref","unstructured":"Martignano F, Gurioli G, Salvi S, Calistri D, Costantini M, Gunelli R et al (2016) GSTP1 methylation and protein expression in prostate cancer: diagnostic implications. Dis Markers","DOI":"10.1155\/2016\/4358292"},{"key":"10812_CR32","doi-asserted-by":"publisher","first-page":"7279243","DOI":"10.1155\/2023\/7279243","volume":"2023","author":"J Ye","year":"2023","unstructured":"Ye J, Wu M, He L, Chen P, Liu H, Yang H (2023) Glutathione-S-Transferase p1 gene promoter methylation in Cell-Free DNA as a diagnostic and prognostic tool for prostate cancer: A systematic review and Meta-Analysis. Int J Endocrinol 2023:7279243","journal-title":"Int J Endocrinol"},{"issue":"5","key":"10812_CR33","first-page":"883","volume":"3","author":"N Syeed","year":"2010","unstructured":"Syeed N, Syed Sameer A, Hamid A et al (2010) Promoter methylation profile of GSTP1 and RASSF1A in benign hyperplasia and metastatic prostate cancer patients in a Kashmiri population. Mol Med Rep 3(5):883\u2013887","journal-title":"Mol Med Rep"},{"issue":"5","key":"10812_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.juro.2014.04.082","volume":"192","author":"L Maldonado","year":"2014","unstructured":"Maldonado L, Brait M, Loyo M, Sullenberger L, Wang K, Peskoe SB et al (2014) GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. J Urol 192(5):1542\u20131548","journal-title":"J Urol"},{"issue":"2","key":"10812_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.juro.2007.09.073","volume":"179","author":"K Woodson","year":"2008","unstructured":"Woodson K, O\u2019Reilly KJ, Hanson JC, Nelson D, Walk EL, Tangrea JA (2008) The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer. J Urol 179(2):508\u2013512","journal-title":"J Urol"},{"key":"10812_CR36","doi-asserted-by":"publisher","first-page":"8472","DOI":"10.1158\/1078-0432.CCR-04-0894","volume":"1023","author":"C Jer\u00f3nimo","year":"2004","unstructured":"Jer\u00f3nimo C, Henrique R, Hoque MO, Mambo E, Ribeiro FR, Varzim G et al (2004) A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 1023:8472\u20138478","journal-title":"Clin Cancer Res"},{"key":"10812_CR37","doi-asserted-by":"crossref","unstructured":"Zhan T et al (2017) Wnt signaling in cancer. Oncogene. 36:1461\u20131473","DOI":"10.1038\/onc.2016.304"},{"issue":"1","key":"10812_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2007.09.056","volume":"71","author":"J Ellinger","year":"2008","unstructured":"Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC et al (2008) CpG Island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate Cancer. Urology 71(1):161\u2013167","journal-title":"Urology"},{"issue":"7","key":"10812_CR39","doi-asserted-by":"publisher","first-page":"e68162","DOI":"10.1371\/journal.pone.0068162","volume":"8","author":"L Richiardi","year":"2013","unstructured":"Richiardi L, Fiano V, Grasso C et al (2013) Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer. PLoS ONE 8(7):e68162","journal-title":"PLoS ONE"},{"issue":"10","key":"10812_CR40","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1002\/ijc.25908","volume":"129","author":"L Liu","year":"2011","unstructured":"Liu L, Kron KJ, Pethe VV, Demetrashvili N, Nesbitt ME, Trachtenberg J et al (2011) Association of tissue promoter methylation levels of APC, TGF\u03b22, HOXD3 and RASSF1A with prostate cancer progression. Int J Cancer 129(10):2454\u20132462","journal-title":"Int J Cancer"},{"key":"10812_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/627249","volume":"2013","author":"A Yaqinuddin","year":"2013","unstructured":"Yaqinuddin A, Qureshi SA, Pervez S, Bashir MU, Nazir R, Abbas F (2013) Frequent DNA hypermethylation at the RASSF1A and APC gene loci in prostate Cancer patients of Pakistani origin. ISRN Urol 2013:1\u20134","journal-title":"ISRN Urol"},{"issue":"2","key":"10812_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/dna.2011.1311","volume":"31","author":"L Delgado-Cruzata","year":"2012","unstructured":"Delgado-Cruzata L, Hruby GW, Gonzalez K, McKiernan J, Benson MC, Santella RM et al (2012) DNA methylation changes correlate with Gleason score and tumor stage in prostate cancer. DNA Cell Biol 31(2):187\u2013192","journal-title":"DNA Cell Biol"},{"issue":"7","key":"10812_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.2174\/138920211797904061","volume":"12","author":"S Majumdar","year":"2011","unstructured":"Majumdar S et al (2011) Aberrant DNA methylation and prostate cancer. Curr Genomics 12(7):486\u2013505","journal-title":"Curr Genomics Vol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10812-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:26:27Z","timestamp":1766895987000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10812"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10812-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Agreement of the Ethics Committee of Biomedical Research in Morocco code: (n\u00b03\/2018\/April 30\/2018- Morocco).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The free and informed consent of all patients involved in this research was obtained, and the confidentiality of their personal information was respected in accordance with ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors approved and consented to publish the presented results.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"711"}}